Login to Your Account

J.P. Morgan Healthcare Conference Opens

'Europe' a Creek, as Emerging Markets Letting Pharma Down

By Randy Osborne
Staff Writer

Monday, January 7, 2013
SAN FRANCISCO – At the lectern and away, talks at the 31st Annual J.P. Morgan Healthcare Conference are sure to concern the steadily worsening revenue shortfall, and how major pharma firms might satisfy profit-hungry shareholders as more casualties topple down the patent cliff.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription